In PCa, MDR1 is frequently methylated at its promoter region (an epigenetic event mostly associated with gene silencing) compared to non-tumorous prostate tissues and has thus been proposed as a PCa biomarker [11-13]. The gene discussed is ABCB1; the disease is posterior cortical atrophy.